PTGS2 and lung carcinoma: PACER is involved in both inflammation and arachidonic acid metabolism and has been implicated in the deregulation of cyclooxygenase-2 (COX-2) in lung cancer [102,103] and dependent trained immunity, specifically against metastatic lung cancer [104].